Stereotaxis (STXS) News Today $1.98 +0.03 (+1.54%) Closing price 03/25/2025 04:10 PM EasternExtended Trading$2.02 +0.04 (+2.27%) As of 03/25/2025 07:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisChartEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Nvidia’s Support Boosts Stereotaxis (STXS) in Advancing Robotic SurgeryMarch 24 at 11:28 AM | msn.comStereotaxis gains support from NVIDIA for AI roboticsMarch 21, 2025 | uk.investing.comStereotaxis says Nvidia highlighted technology at NVIDIA GTCMarch 19, 2025 | markets.businessinsider.comStereotaxis (STXS) Gets a Buy from Lake StreetMarch 19, 2025 | markets.businessinsider.comStereotaxis Highlighted by NVIDIA at GTC Artificial Intelligence Conference and Accepted into NVIDIA Connect ProgramMarch 19, 2025 | globenewswire.comPaul J. Isaac Acquires 38,000 Shares of Stereotaxis, Inc. (NYSEAMERICAN:STXS) StockStereotaxis, Inc. (NYSEAMERICAN:STXS - Get Free Report) Director Paul J. Isaac purchased 38,000 shares of the company's stock in a transaction that occurred on Monday, March 10th. The shares were purchased at an average price of $1.81 per share, for a total transaction of $68,780.00. Following the completion of the transaction, the director now directly owns 87,299 shares of the company's stock, valued at $158,011.19. This represents a 77.08 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.March 12, 2025 | marketbeat.comStereotaxis, Inc. (NYSEAMERICAN:STXS) Director Buys $68,780.00 in StockMarch 12, 2025 | insidertrades.comStereotaxis, Inc. (NYSEAMERICAN:STXS) Director Buys $42,171.19 in StockStereotaxis, Inc. (NYSEAMERICAN:STXS - Get Free Report) Director Paul J. Isaac purchased 23,299 shares of the company's stock in a transaction on Thursday, March 6th. The shares were purchased at an average cost of $1.81 per share, with a total value of $42,171.19. Following the transaction, the director now directly owns 49,066 shares in the company, valued at $88,809.46. This trade represents a 90.42 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is available through this hyperlink.March 11, 2025 | marketbeat.comPaul J. Isaac Purchases 23,299 Shares of Stereotaxis, Inc. (NYSEAMERICAN:STXS) StockMarch 11, 2025 | insidertrades.comStereotaxis to Present at 37th Annual Roth ConferenceMarch 10, 2025 | globenewswire.comEssex Investment Management Co. LLC Sells 197,165 Shares of Stereotaxis, Inc. (NYSEAMERICAN:STXS)Essex Investment Management Co. LLC trimmed its holdings in shares of Stereotaxis, Inc. (NYSEAMERICAN:STXS - Free Report) by 14.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 1,212,964 shares of the company's stock after sellinMarch 10, 2025 | marketbeat.comStereotaxis To Get FDA Approval Of MAGiC This Fall, Ending Cash BurnMarch 7, 2025 | seekingalpha.comQ1 Earnings Estimate for Stereotaxis Issued By Roth CapitalStereotaxis, Inc. (NYSEAMERICAN:STXS - Free Report) - Roth Capital cut their Q1 2025 earnings per share (EPS) estimates for shares of Stereotaxis in a report issued on Tuesday, March 4th. Roth Capital analyst J. Wittes now forecasts that the company will post earnings of ($0.07) per share for theMarch 7, 2025 | marketbeat.comStereotaxis, Inc. (STXS) Q4 2024 Earnings Call TranscriptMarch 5, 2025 | seekingalpha.comStereotaxis announces FDA regulatory submission for MAGiC Sweep catheterMarch 4, 2025 | finance.yahoo.comStereotaxis, Inc. (AMEX:STXS) Q4 2024 Earnings Call TranscriptMarch 4, 2025 | msn.comStereotaxis, Inc.: Stereotaxis Submits EMAGIN Catheter for Regulatory Clearance as it Pioneers Robotics for Endovascular SurgeryMarch 3, 2025 | finanznachrichten.deStereotaxis, Inc.: Stereotaxis Reports 2024 Full Year Financial ResultsMarch 3, 2025 | finanznachrichten.deStereotaxis submits EMAGIN catheter for regulatory clearanceMarch 3, 2025 | markets.businessinsider.comStereotaxis sees double digit revenue growth for FY25March 3, 2025 | markets.businessinsider.comStereotaxis Submits EMAGIN Catheter for Regulatory Clearance as it Pioneers Robotics for Endovascular SurgeryMarch 3, 2025 | globenewswire.comStereotaxis Submits First Ever Robotically Navigated High-Density EP Mapping Catheter for Regulatory ClearanceMarch 3, 2025 | globenewswire.comStereotaxis Reports 2024 Full Year Financial ResultsMarch 3, 2025 | globenewswire.comStereotaxis Q4 2024 Earnings PreviewFebruary 28, 2025 | msn.comStereotaxis to Present at 45th Annual TD Cowen Healthcare ConferenceFebruary 25, 2025 | globenewswire.comStereotaxis (STXS) to Release Earnings on MondayStereotaxis (NYSEAMERICAN:STXS) will be releasing earnings before the market opens on Monday, March 3. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=661839)February 24, 2025 | marketbeat.comStock Market Sleeps On Stereotaxis MAGiC CE MarkFebruary 14, 2025 | seekingalpha.comLegato Capital Management LLC Cuts Position in Stereotaxis, Inc. (NYSEAMERICAN:STXS)Legato Capital Management LLC trimmed its position in Stereotaxis, Inc. (NYSEAMERICAN:STXS - Free Report) by 23.7% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 360,291 shares of the company's stocFebruary 14, 2025 | marketbeat.comStereotaxis to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025February 3, 2025 | globenewswire.comPrecio de las acciones, noticias, cotización e historial de Stereotaxis, Inc. (STXS) - Yahoo FinanzasFebruary 2, 2025 | finance.yahoo.comTD Cowen Keeps Their Buy Rating on Stereotaxis (STXS)January 31, 2025 | markets.businessinsider.comTD Cowen Reaffirms Their Buy Rating on Stereotaxis (STXS)January 31, 2025 | markets.businessinsider.comStereotaxis Announces First GenesisX Robotic System OrderJanuary 30, 2025 | globenewswire.comStereotaxis receives CE Mark approval for MAGiC ablation catheterJanuary 28, 2025 | markets.businessinsider.comLake Street Remains a Buy on Stereotaxis (STXS)January 28, 2025 | markets.businessinsider.comStereotaxis, Inc.: Stereotaxis Receives CE Mark Approval for the MAGiC Ablation CatheterJanuary 27, 2025 | finanznachrichten.deStereotaxis Hikes on Winning European ApprovalJanuary 27, 2025 | baystreet.caStereotaxis Receives CE Mark Approval for the MAGiC Ablation CatheterJanuary 27, 2025 | globenewswire.comTraynor Capital Management Inc. Acquires Shares of 160,509 Stereotaxis, Inc. (NYSEAMERICAN:STXS)Traynor Capital Management Inc. bought a new position in shares of Stereotaxis, Inc. (NYSEAMERICAN:STXS - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 160,509 shares of the company's stock, valuedJanuary 24, 2025 | marketbeat.comStereotaxis Positioned for 2025 Growth: Buy Rating Backed by Strong Pipeline, Regulatory Approvals, and Solid FinancialsJanuary 17, 2025 | markets.businessinsider.comStereotaxis announces Genesis RMN use by Oulu University HospitalJanuary 14, 2025 | markets.businessinsider.comOulu University Hospital Enhances Leadership in Arrhythmia Care with Advanced Genesis Robotic TechnologyJanuary 14, 2025 | globenewswire.comWhy Stereotaxis (STXS) Is Among the Cheap Robotics Stocks to Invest In Now?January 13, 2025 | msn.comStereotaxis (NYSEAMERICAN:STXS) Shares Down 2.2% - Here's WhyStereotaxis (NYSEAMERICAN:STXS) Stock Price Down 2.2% - Here's What HappenedDecember 13, 2024 | marketbeat.comStereotaxis, Medtech announce catheter approved by China’s NMPADecember 9, 2024 | markets.businessinsider.comStereotaxis’s Strategic Advancements and Chinese Market Potential Drive Buy RatingDecember 9, 2024 | markets.businessinsider.comMagbot Robotic Magnetic Navigation Ablation Catheter Approved by China’s NMPADecember 9, 2024 | finance.yahoo.comMagbot Robotic Magnetic Navigation Ablation Catheter Approved by China's NMPADecember 9, 2024 | globenewswire.comStereotaxis’ GenesisX Robotic System to be Showcased for the First Time at RSNA 2024 by Neusoft Medical SystemsDecember 2, 2024 | finance.yahoo.comStereotaxis' GenesisX Robotic System to be Showcased for the First Time at RSNA 2024 by Neusoft Medical SystemsDecember 2, 2024 | globenewswire.com Remove Ads Get Stereotaxis News Delivered to You Automatically Sign up to receive the latest news and ratings for STXS and its competitors with MarketBeat's FREE daily newsletter. Email Address STXS Media Mentions By Week STXS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. STXS News Sentiment▼0.500.77▲Average Medical News Sentiment STXS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. STXS Articles This Week▼52▲STXS Articles Average Week Remove Ads Get Stereotaxis News Delivered to You Automatically Sign up to receive the latest news and ratings for STXS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BBNX News Today SIBN News Today KIDS News Today OM News Today TMCI News Today WEDXF News Today DCTH News Today SMLR News Today NPCE News Today NYXH News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSEAMERICAN:STXS) was last updated on 3/26/2025 by MarketBeat.com Staff From Our PartnersTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredDOGE could send 6 AI stocks through the roofStay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredNvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry."If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredThis Crypto Is Set to Explode in FebruaryBryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Stereotaxis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Stereotaxis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.